Brainstorm Cell Therapeutics, Inc. (BCLI)
0.9302
-0.07
(-6.98%)
USD |
OTCM |
Oct 02, 16:00
Brainstorm Cell Therapeutics Price : 0.9302 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 0.946 | 1.03 | 0.90 | 0.9302 | 16625.00 |
| Oct 01, 2026 | 0.9430 | 1.08 | 0.922 | 1.00 | 17436.00 |
| Sep 30, 2026 | 0.88 | 0.95 | 0.88 | 0.95 | 7748.00 |
| Sep 29, 2026 | 0.92 | 0.92 | 0.92 | 0.92 | 865.00 |
| Sep 28, 2026 | 0.9055 | 0.965 | 0.9055 | 0.936 | 1380.00 |
| Sep 25, 2026 | 0.979 | 0.979 | 0.96 | 0.97 | 20573.00 |
| Sep 24, 2026 | 0.989 | 1.08 | 0.92 | 0.9498 | 18981.00 |
| Sep 23, 2026 | 0.8331 | 0.99 | 0.8331 | 0.8701 | 1652.00 |
| Sep 22, 2026 | 0.87 | 0.9434 | 0.87 | 0.9434 | 2160.00 |
| Sep 21, 2026 | 0.8701 | 0.90 | 0.85 | 0.87 | 17662.00 |
| Sep 18, 2026 | 1.00 | 1.00 | 0.8549 | 0.90 | 26796.00 |
| Sep 17, 2026 | 0.9301 | 1.03 | 0.92 | 0.98 | 8443.00 |
| Sep 16, 2026 | 0.968 | 1.01 | 0.9201 | 0.9790 | 32883.00 |
| Sep 15, 2026 | 1.06 | 1.08 | 0.9593 | 1.04 | 7584.00 |
| Sep 14, 2026 | 1.06 | 1.074 | 1.06 | 1.063 | 1777.00 |
| Sep 11, 2026 | 1.055 | 1.08 | 1.02 | 1.08 | 42883.00 |
| Sep 10, 2026 | 1.00 | 1.07 | 1.00 | 1.03 | 17947.00 |
| Sep 09, 2026 | 0.98 | 1.06 | 0.98 | 1.00 | 6898.00 |
| Sep 08, 2026 | 1.00 | 1.05 | 0.98 | 0.99 | 6890.00 |
| Sep 04, 2026 | 1.06 | 1.06 | 1.03 | 1.05 | 7211.00 |
| Sep 03, 2026 | 1.26 | 1.34 | 1.05 | 1.07 | 42391.00 |
| Sep 02, 2026 | 1.184 | 1.30 | 1.13 | 1.25 | 19576.00 |
| Sep 01, 2026 | 1.08 | 1.19 | 1.03 | 1.168 | 3724.00 |
| Aug 31, 2026 | 1.07 | 1.086 | 0.98 | 1.065 | 23401.00 |
| Aug 28, 2026 | 1.15 | 1.19 | 1.07 | 1.123 | 3634.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0095 |
| Summit Therapeutics, Inc. | 16.76 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 2.70 |
| Clene, Inc. | 4.08 |
Price Related Metrics
| Earnings Yield | -102.6% |
| Market Cap | 10.26M |